Ethanol
Ethanol is a topic covered in the Washington Manual of Medical Therapeutics.
To view the entire topic, please log in or purchase a subscription.
The Washington Manual is an award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Explore these free sample topics:
-- The first section of this topic is shown below --
General Principles
Pathophysiology
- Ethanol enhances inhibitory signaling through the GABA-A receptor and suppresses excitatory signaling through the NMDA glutamate receptor.
- Over time, patients with chronic heavy ethanol use will develop profound tolerance to the effects of ethanol.
- This occurs via qualitative changes in GABA-A receptors which render them less sensitive to activation, and via quantitative upregulation of NMDA receptors.
- Ethanol is eliminated primarily by the alcohol dehydrogenase pathway; elimination follows zero-order kinetics.
- Acute and chronic heavy ethanol use have many deleterious health effects that are outside the scope of this chapter (e.g., alcoholic hepatitis, pancreatitis, cardiomyopathy, peptic ulcer disease, cancers).
-- To view the remaining sections of this topic, please log in or purchase a subscription --
General Principles
Pathophysiology
- Ethanol enhances inhibitory signaling through the GABA-A receptor and suppresses excitatory signaling through the NMDA glutamate receptor.
- Over time, patients with chronic heavy ethanol use will develop profound tolerance to the effects of ethanol.
- This occurs via qualitative changes in GABA-A receptors which render them less sensitive to activation, and via quantitative upregulation of NMDA receptors.
- Ethanol is eliminated primarily by the alcohol dehydrogenase pathway; elimination follows zero-order kinetics.
- Acute and chronic heavy ethanol use have many deleterious health effects that are outside the scope of this chapter (e.g., alcoholic hepatitis, pancreatitis, cardiomyopathy, peptic ulcer disease, cancers).
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Bhat, Pavat, et al., editors. "Ethanol." Washington Manual of Medical Therapeutics, 35th ed., Wolters Kluwer Health, 2016. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602676/all/Ethanol.
Ethanol. In: Bhat PP, Dretler AA, Gdowski MM, et al, eds. Washington Manual of Medical Therapeutics. Wolters Kluwer Health; 2016. https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602676/all/Ethanol. Accessed April 1, 2023.
Ethanol. (2016). In Bhat, P., Dretler, A., Gdowski, M., Ramgopal, R., & Williams, D. (Eds.), Washington Manual of Medical Therapeutics (35th ed.). Wolters Kluwer Health. https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602676/all/Ethanol
Ethanol [Internet]. In: Bhat PP, Dretler AA, Gdowski MM, Ramgopal RR, Williams DD, editors. Washington Manual of Medical Therapeutics. Wolters Kluwer Health; 2016. [cited 2023 April 01]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602676/all/Ethanol.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ethanol
ID - 602676
ED - Williams,Dominique,
ED - Bhat,Pavat,
ED - Dretler,Alexandra,
ED - Gdowski,Mark,
ED - Ramgopal,Rajeev,
BT - Washington Manual of Medical Therapeutics
UR - https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602676/all/Ethanol
PB - Wolters Kluwer Health
ET - 35
DB - The Washington Manual
DP - Unbound Medicine
ER -